Pharmaceuticals, Biotechnology and Life Sciences
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial…
Fourth quarter net sales of $21.2 million, gross margin of 61.0%, and net income of $0.1 million. Full year net…
LONDON–(BUSINESS WIRE)–ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders,…
Agathos records first sale of recombinant adeno-associated virus produced using AE1-BHK to collaborator Genovac; provides free access to AE1-BHK cell…
DUBLIN–(BUSINESS WIRE)–The “Artificial Intelligence in Drug Discovery Market in India, 2024” report has been added to ResearchAndMarkets.com’s offering. The Indian…
DUBLIN–(BUSINESS WIRE)–The “Psoriatic Arthritis – Pipeline Insight, 2024” clinical trials has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive…
DUBLIN–(BUSINESS WIRE)–The “Anterior Uveitis – Pipeline Insight, 2024” clinical trials has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive…
Expanded personalized population health capabilities support better health journeys for patients SAN ANTONIO, Texas–(BUSINESS WIRE)–Carenet Health, a trusted partner in…
THIO and ionizing radiation combination shown to significantly decrease cell proliferation and produce potent anticancer effects in highly aggressive, treatment-resistant…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–#alzheimers—Cognito Therapeutics, a leader in technology-based therapeutic interventions for neurodegenerative diseases, announced today the publication of the OVERTURE…